Cite Filings / CLRB / 0001622627-25-000002

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Cellectar Biosciences, Inc. Filed 2025-02-03 Acc 0001622627-25-000002

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-06 EFFECT Notice of Effectiveness
2025-02-04 CORRESP Correspondence Between Filers and SEC Staff
2025-02-03 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-03 UPLOAD SEC-generated Letter
2025-01-31 8-K Delisting notice
2025-01-27 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…